[go: up one dir, main page]

FI952953L - Medel för behandling av metaboliska benstommesjukdomar - Google Patents

Medel för behandling av metaboliska benstommesjukdomar Download PDF

Info

Publication number
FI952953L
FI952953L FI952953A FI952953A FI952953L FI 952953 L FI952953 L FI 952953L FI 952953 A FI952953 A FI 952953A FI 952953 A FI952953 A FI 952953A FI 952953 L FI952953 L FI 952953L
Authority
FI
Finland
Prior art keywords
agents
treatment
bone diseases
metabolic bone
metabolic
Prior art date
Application number
FI952953A
Other languages
English (en)
Finnish (fi)
Other versions
FI952953A0 (sv
Inventor
Masakazu Katoh
Kazuyuki Kitamura
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of FI952953A0 publication Critical patent/FI952953A0/sv
Publication of FI952953L publication Critical patent/FI952953L/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • A61K38/2006IL-1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI952953A 1994-06-17 1995-06-15 Medel för behandling av metaboliska benstommesjukdomar FI952953L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6135275A JPH083058A (ja) 1994-06-17 1994-06-17 新規な骨代謝疾患治療剤

Publications (2)

Publication Number Publication Date
FI952953A0 FI952953A0 (sv) 1995-06-15
FI952953L true FI952953L (sv) 1995-12-18

Family

ID=15147903

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952953A FI952953L (sv) 1994-06-17 1995-06-15 Medel för behandling av metaboliska benstommesjukdomar

Country Status (10)

Country Link
US (1) US5726148A (sv)
EP (1) EP0687470A3 (sv)
JP (1) JPH083058A (sv)
KR (1) KR960000248A (sv)
AU (1) AU697136B2 (sv)
CA (1) CA2152023A1 (sv)
FI (1) FI952953L (sv)
HU (1) HU218947B (sv)
NO (1) NO952411L (sv)
TW (1) TW496740B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020028798A1 (en) * 1995-12-12 2002-03-07 Omeros Medical Systems Irrigation solution and method for inhibition of pain and inflammation
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
US7029861B1 (en) 1998-09-15 2006-04-18 Board Of Regents, The University Of Texas System LPS-response gene compositions and methods
JP3755564B2 (ja) 1999-05-24 2006-03-15 株式会社村田製作所 圧電共振部品及びその製造方法
RU2271825C2 (ru) 1999-07-21 2006-03-20 Омерос Корпорейшн Растворы и способы ингибирования боли, воспаления и разрушения хряща
US20050074434A1 (en) * 2001-02-23 2005-04-07 Tomoaki Hoshino Remedies for metabolic bone diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004838A1 (en) * 1987-11-25 1989-06-01 Immunex Corporation Interleukin-1 receptors
US4968607A (en) * 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5319071A (en) * 1987-11-25 1994-06-07 Immunex Corporation Soluble interleukin-1 receptors
WO1991000742A1 (en) * 1989-07-07 1991-01-24 E.I. Du Pont De Nemours And Company Soluble human b-cell interleukin-1 receptor
EP0474141B1 (en) * 1990-09-03 1996-01-31 Kuraray Co., Ltd. Peptide or its salts
EP0563239A4 (en) * 1990-12-20 1994-10-12 Univ Pittsburgh A truncated interleukin-1 receptor gene for the treatment of arthritis.

Also Published As

Publication number Publication date
KR960000248A (ko) 1996-01-25
NO952411L (no) 1995-12-18
HU218947B (hu) 2001-01-29
US5726148A (en) 1998-03-10
NO952411D0 (no) 1995-06-16
HUT72054A (en) 1996-03-28
EP0687470A3 (en) 1996-06-19
TW496740B (en) 2002-08-01
AU2171695A (en) 1996-01-04
AU697136B2 (en) 1998-09-24
JPH083058A (ja) 1996-01-09
HU9501779D0 (en) 1995-08-28
CA2152023A1 (en) 1995-12-18
EP0687470A2 (en) 1995-12-20
FI952953A0 (sv) 1995-06-15

Similar Documents

Publication Publication Date Title
CY2018020I2 (el) Θεραπεια της νοσου ρομρε
FI952721L (sv) Medel för behandling av lever-gall-sjukdomar
DE69522448D1 (de) Gewebebehandlungskassette
FI963696L (sv) Gel för hudsjukdomsterapi och desinfektering av hud
DE69524138D1 (de) Hautbehandlungsmittel
DE69509544D1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
EE03512B1 (et) Epinastiin kasutamiseks valude ravis
EE9900469A (et) Sulfoonamiidid endoteliini vahendatud haiguste raviks
FI970682L (sv) Anatomiskt utformad kombinerad sanitetsbinda
EE200300214A (et) Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks
NO20001869D0 (no) Fremgangsmõte for behandling av Alzheimerssykdom
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
IL129144A0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
FI971527L (sv) Användning av indolderivat för behandling av olika sjukdomar
ID23528A (id) Pengobatan terapeutik untuk gangguan kulit
FI952953L (sv) Medel för behandling av metaboliska benstommesjukdomar
EE03437B1 (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
NO982562D0 (no) Sammensetning for behandling av smerte
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
DE69636790D1 (de) Interferon-beta gegen knochenerkrankungen
FI963263A0 (sv) Medicinsk användning av bromelain
ID24922A (id) Terapi kombinasi untuk pengobatan aids
DE69000791D1 (de) Therapeutische mittel fuer metabolische knochenkrankheiten.
EP0755262A4 (en) PNEUMOPATHY TREATMENT COMPOSITION
DE69813354D1 (de) Mittel zur Behandlung von Herzkrankheiten